Jing-Gung Chung

Title: The Innovative Contributions of Jing-Gung Chung

Introduction

Jing-Gung Chung is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of anticancer agents, holding a total of five patents. His innovative work focuses on the synthesis of novel compounds that exhibit promising anticancer activities.

Latest Patents

Among his latest patents are the development of 2-phenyl-4-quinolones and 2-selenophene-4-quinolones as anticancer agents. These compounds are synthesized by converting 2-aryl-4-quinolones into phosphates through a reaction with tetrabenzyl pyrophosphate. This process forms dibenzyl phosphates, which are then hydrogenated to replace dibenzyl groups with hydrogen. The resulting compounds are reacted with Amberlite IR-120 (Na form) to create disodium salts. Preliminary screening results indicate that these phosphates demonstrate significant anti-cancer activity. Additionally, novel intermediates such as 2-selenophene 4-quinolone and N,N-dialkylaminoalkyl derivatives of 2-phenyl-4-quinolones have also been synthesized, showcasing significant anticancer activities.

Career Highlights

Jing-Gung Chung has worked with notable institutions, including China Medical University and Tairx, Inc. His research has contributed to advancements in the development of effective anticancer therapies. His innovative approaches and dedication to research have positioned him as a key figure in his field.

Collaborations

Some of his notable coworkers include Sheng-Chu Kuo and Kuo-Hsiung Lee. Their collaborative efforts have further enhanced the impact of Chung's research in the scientific community.

Conclusion

Jing-Gung Chung's work in the synthesis of anticancer agents has made a significant impact in the field of medicinal chemistry. His innovative contributions continue to pave the way for new therapeutic options in cancer treatment.